GILENYA 0,5 mg, gélule — 7 plaquettes thermoformées unidoses perforées PVC PVDC aluminium de 1 gélule

Medicine package · Base de données publique des médicaments (BDPM), ANSM, HAS et Assurance Maladie · France

  • CIP13 3400941778537
  • CIP7 4177853
  • CIS 60728597
  • Registration number EU/1/11/677

What the source publishes

Holder
NOVARTIS EUROPHARM (IRLANDE)
Active ingredients
FINGOLIMOD, CHLORHYDRATE DE FINGOLIMOD
Form
gélule
Package
7 plaquettes thermoformées unidoses perforées PVC PVDC aluminium de 1 gélule
Routes
orale
Administrative status
authorised
Supply regime
prescription réservée aux spécialistes et services NEUROLOGIE ; médicament nécessitant une surveillance particulière pendant le traitement ; prescription initiale hospitalière annuelle ; liste I ; la première administration doit être effectuée en milieu hospitalier ; prescription réservée aux spécialistes et services NEUROPEDIATRIE
Marketing status
Déclaration de commercialisation
Authorised on
2011-03-17
Prescription
Prescription or restricted

Names this record is found by

Complete source data
fr:ansm:packages:3400941778537
{
  "cis": "60728597",
  "cip7": "4177853",
  "form": "gélule",
  "name": "GILENYA 0,5 mg, gélule — 7 plaquettes thermoformées unidoses perforées PVC PVDC aluminium de 1 gélule",
  "cip13": "3400941778537",
  "holder": "NOVARTIS EUROPHARM (IRLANDE)",
  "routes": [
    "orale"
  ],
  "holders": [
    "NOVARTIS EUROPHARM (IRLANDE)"
  ],
  "currency": "EUR",
  "marketed": true,
  "bdmStatus": null,
  "useDomain": "unknown",
  "publicPrice": null,
  "authorisedOn": "2011-03-17",
  "compositions": [
    {
      "name": "FINGOLIMOD",
      "nature": "FT",
      "strength": "0,5 mg",
      "linkageNumber": "1",
      "substanceCode": "85211",
      "dosageReference": "une gélule",
      "pharmaceuticalElement": "gélule"
    },
    {
      "name": "CHLORHYDRATE DE FINGOLIMOD",
      "nature": "SA",
      "strength": "0,56 mg",
      "linkageNumber": "1",
      "substanceCode": "97368",
      "dosageReference": "une gélule",
      "pharmaceuticalElement": "gélule"
    }
  ],
  "sourceStatus": "Présentation active",
  "supplyRegime": "prescription réservée aux spécialistes et services NEUROLOGIE ; médicament nécessitant une surveillance particulière pendant le traitement ; prescription initiale hospitalière annuelle ; liste I ; la première administration doit être effectuée en milieu hospitalier ; prescription réservée aux spécialistes et services NEUROPEDIATRIE",
  "dispensingFee": null,
  "medicinePrice": null,
  "regionalRules": "not-collected",
  "targetSpecies": [],
  "specialityName": "GILENYA 0,5 mg, gélule",
  "marketingStatus": "Déclaration de commercialisation",
  "publicationDates": {
    "CIS_bdpm": "2026-11-20",
    "CIS_CIP_bdpm": "2026-11-20",
    "CIS_CPD_bdpm": "2026-11-20",
    "CIS_COMPO_bdpm": "2026-11-20"
  },
  "specialityListed": true,
  "useDomainEvidence": {
    "basis": "unreviewed",
    "field": null,
    "value": null,
    "version": 1,
    "sourceId": "fr.ansm.bdpm"
  },
  "collectiveApproval": "oui",
  "packageDescription": "7 plaquettes thermoformées unidoses perforées PVC PVDC aluminium de 1 gélule",
  "patientEligibility": "not-assessed",
  "reimbursementRates": [],
  "marketingDeclaredOn": "2011-12-19",
  "targetSpeciesStatus": "not-reported",
  "additionalMonitoring": false,
  "administrativeStatus": "authorised",
  "prescriptionCategory": "prescription-or-restricted",
  "activeIngredientNames": [
    "FINGOLIMOD",
    "CHLORHYDRATE DE FINGOLIMOD"
  ],
  "authorisationProcedure": "Procédure centralisée",
  "prescriptionConditions": [
    "prescription réservée aux spécialistes et services NEUROLOGIE",
    "médicament nécessitant une surveillance particulière pendant le traitement",
    "prescription initiale hospitalière annuelle",
    "liste I",
    "la première administration doit être effectuée en milieu hospitalier",
    "prescription réservée aux spécialistes et services NEUROPEDIATRIE"
  ],
  "reimbursementIndications": null,
  "authorisationSourceStatus": "Autorisation active",
  "europeanAuthorisationNumber": "EU/1/11/677",
  "presentationAdministrativeStatus": "authorised"
}

Read this record from your own software

The same record, with every field and its provenance, is one request away. An API key is free and works immediately.

GET /v1/drugs/record
curl -G "https://api.medifontis.com/v1/drugs/record" \
  -H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
  --data-urlencode "country=fr" \
  --data-urlencode "sourceId=fr.ansm.bdpm" \
  --data-urlencode "id=fr:ansm:packages:3400941778537"